The China PGT (Preimplantation Genetic Testing) Services Market is expected to grow by US$ 4.8 billion during 2020-2026, progressing at a CAGR of 59.1% during the forecast period.

This industry report offers market estimates and forecasts of the China market, followed by a detailed analysis of the type. The China market data on PGT (preimplantation genetic testing) services can be segmented by type: preimplantation genetic testing for aneuploidies (PGT-A), preimplantation genetic testing for monogenic (PGT-M), and preimplantation genetic testing for structural chromosomal rearrangements (PGT-SR). The preimplantation genetic testing for aneuploidies (PGT-A) segment held the largest market share in 2019. However, the preimplantation genetic testing for monogenic (PGT-M) segment is expected to witness the highest CAGR during the forecast period.

The study provides historical market data (2016-2019) and forecasts from 2020 till 2026. The market size and estimations are provided in terms of revenue (million USD) considering 2019 as base year and market forecast will be given from 2020 to 2026.

The data-centric report focuses on market trends, status and outlook for segments, and future growth. With comprehensive coverage of the market across different market segments the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?

Get a detailed picture of the China PGT (Preimplantation Genetic Testing) Services Market
Identify segments/areas to invest in over the forecast period in the China PGT (Preimplantation Genetic Testing) Services Market
Understand the competitive environment, the markets leading players